Combating Illicit Xylazine Act

Hozzl · 2025-03-13T15:23:23Z

Explore the details of House Bill 1266 Combating Illicit Xylazine Act currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on undefined. Stay informed on legislative developments.

3/13/2025, 3:23 PM

Summary of Bill HR 1266

Bill 119 HR 1266, also known as the "Xylazine Prohibition Act," aims to restrict the use of xylazine for certain purposes. Xylazine is a sedative commonly used in veterinary medicine, but it has also been misused as a recreational drug and in criminal activities.

The bill prohibits the use of xylazine for non-medical purposes, such as in the production or distribution of illicit drugs. It also prohibits the use of xylazine in any form of animal fighting, including cockfighting and dogfighting.

Additionally, the bill includes provisions for increased penalties for individuals found in violation of the xylazine prohibition. This includes fines and potential imprisonment for those caught using xylazine for illegal purposes. Overall, the Xylazine Prohibition Act seeks to address the misuse of xylazine and protect both animals and communities from the harmful effects of its misuse.

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill HR 1266

Bill HR 1266 is currently in the status of Bill Introduced since February 12, 2025. Bill HR 1266 was introduced during Congress 119 and was introduced to the House on February 12, 2025. Bill HR 1266's most recent activity was Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. as of February 12, 2025